Influence of HCV genotype 1 subtypes on the virus response to PEG interferon alpha-2a plus ribavirin therapy.
Nicot F, Alric L, Barange K, Métivier S, Dramard JM, Combis JM, Castan B, Meurisse JJ, Payen JL, Garipuy D, Desmorat H, Peron JM, Thebault S, Morin T, Renou C, Barel P, Guerin B, Imbert Y, Sire S, Sauné K, Chatelut E, Izopet J.
Nicot F, et al. Among authors: saune k.
J Med Virol. 2011 Mar;83(3):437-44. doi: 10.1002/jmv.21976.
J Med Virol. 2011.
PMID: 21264864
Clinical Trial.